Here, the increase in IL‐22 levels during the invasion stage could be due to increased presence of these cells in the TME as in the MMTV‐PyMT breast cancer model, leukocyte infiltration in breast tumor tissues occurs between the early carcinoma and late carcinoma stages (Lin et al., 2003). This evidence concerns the gene IL22 and carcinoma.